A new survey suggests that some people who were once hesitant about a COVID-19 vaccine may be inclined to get the shot today.
Researchers from Emory University in Atlanta published their findings “Journal of the American Medical Association” After surveying more than 4,600 people between August and December 2020, just before the first vaccine was launched. More than 3,400 of them responded to a follow-up survey between March and April 2021.
For those who were initially vaccine-hesitating, the results showed that some had changed their mind by the time of the follow-up survey: 32% of respondents had received at least one or more doses of a COVID-19 vaccine, 37% said they were likely to be vaccinated and 32% said they would remain unvaccinated.
For those who were initially interested in getting the vaccine, the results of the follow-up survey showed that 54% of respondents received one or more doses of the vaccine, 39% said they were likely to get the vaccine, and 7% expressed their opinion. changed and said they were likely to remain uninfected.
The researchers noted that the desire for an early vaccine was higher among college-educated people who had a lower level of education. Researchers observed similar differences during the follow-up survey with those who received the vaccine compared with those who did not.
The researchers also noted that they saw almost the same number of Hispanic and non-Hispanic whites who were previously willing to receive the vaccine. But by the time of the follow-up survey, more non-Hispanic whites had been vaccinated than Hispanics.
The researchers did not explain why the hesitation of the vaccine seems to be decreasing for months. Still, it comes after US health officials and the Biden administration worked years to address vaccine hesitation. Some states and companies even offered financial incentives to encourage people to get vaccinated.
Nevertheless, according to U.S. Centers for Disease Control and Prevention, 65.6% of Americans age 12 and older are fully vaccinated. An estimated 70 million eligible Americans have not been vaccinated, providing kindling for the delta variant and further opportunities for incubation of other worrying mutations.
This is the case despite a growing number of businesses announcing vaccination requirements for their employees, including Google, McDonald’s, Microsoft and Disney. In addition, large cities such as New York and San Francisco are demanding vaccinations for people to eat in restaurants or enter certain other businesses.
Dr. Anthony Fauci says he is concerned that those opposing COVID-19 vaccine shots on religious grounds may confuse that with the philosophical objection. Fauci, who is chief medical adviser to President Joe Biden, says getting a COVID-19 vaccine is no different in concept than getting it for other vaccines, such as measles, which have been done for many years. Is. He says a public health review found “very, very few, literally less than a handful” of established religions that actually oppose vaccination.
US health officials have also warned repeatedly that unvaccinated Americans are at greater risk of severe symptoms and hospitalization if they contract COVID-19.
New US studies released last month showed COVID-19 vaccines are highly effective against hospitalization and death, even as the extra-infectious delta version swept the country.
One study tracked more than 600,000 COVID-19 cases in 13 states from April to mid-July. As the more infectious COVID-19 delta variant increased in early summer, people who were not vaccinated were 4.5 times more likely to be infected, 10 times more likely to be hospitalized than those who were fully vaccinated and were 11 times more likely to die. CDC.
In September, the US Food and Drug Administration Pfizer-BioNtech authorizes third booster shot of vaccine For Americans who are 65 and older, young adults with underlying health conditions and in jobs that put them at higher risk for COVID-19. Under FDA authorization, vaccinated Americans are eligible for a third dose six months after receiving their second Pfizer shot.
The FDA is convening its external panel of advisors next week to review booster data for both Johnson & Johnson and Moderna and their vaccines.
This story was reported from Los Angeles.